4th International Conference on
Non Communicable Diseases

"Prevention & Control of NCD"

Paper/Abstract Submission Deadline :

Important Dates
  • Paper/Abstract submission deadline : 29th December 2026
  • Notification of acceptance : Within 21 Days (+/-3)
  • Full paper submission deadline : 28th February 2027
  • Registration Deadline : 5th February 2027
  • Conference Date :
Scope

Cardiovascular Diseases (CVDs)

  • Hypertension, coronary artery disease & heart failure
  • Stroke prevention & rehabilitation
  • Atherosclerosis & lipid disorders
  • Arrhythmias & sudden cardiac death
  • Rheumatic heart disease in low-resource settings
  • Novel anticoagulants & antiplatelet therapies
  • Cardiac imaging & biomarkers
  • Cardiac rehabilitation & lifestyle interventions

Diabetes & Metabolic Disorders

  • Type 1 & Type 2 diabetes mellitus
  • Gestational diabetes & maternal-fetal outcomes
  • Insulin resistance & metabolic syndrome
  • Obesity as a disease & its management
  • Diabetic complications (retinopathy, nephropathy, neuropathy)
  • Continuous glucose monitoring & insulin pumps
  • Bariatric surgery & metabolic interventions
  • Prediabetes screening & prevention programs

Cancer (Oncology)

  • Breast, lung, colorectal, prostate & cervical cancers
  • Hematological malignancies (leukemia, lymphoma)
  • Pediatric oncology & survivorship
  • Cancer screening, early detection & biomarkers
  • Immunotherapy, targeted therapy & precision oncology
  • Palliative care & pain management
  • Psycho-oncology & quality of life
  • Cancer registry & epidemiology

Chronic Respiratory Diseases

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma: Phenotypes, biologics & management
  • Interstitial lung diseases & pulmonary fibrosis
  • Sleep apnea & respiratory comorbidities
  • Pulmonary rehabilitation & oxygen therapy
  • Air pollution & respiratory health
  • Smoking cessation & tobacco control
  • Occupational lung diseases

Mental Health & Neurological Disorders

  • Depression, anxiety & stress-related disorders
  • Schizophrenia & bipolar disorder
  • Substance use disorders & addiction medicine
  • Dementia, Alzheimer's & cognitive decline
  • Parkinson's disease & movement disorders
  • Epilepsy & seizure management
  • Multiple sclerosis & neuroimmunology
  • Suicide prevention & mental health first aid
  • Integration of mental health into NCD care

Chronic Kidney Disease (CKD)

  • Diabetic & hypertensive nephropathy
  • Glomerular diseases & interstitial nephritis
  • CKD-mineral & bone disorder (CKD-MBD)
  • Anemia in CKD & iron metabolism
  • Dialysis (hemodialysis & peritoneal dialysis)
  • Kidney transplantation & immunosuppression
  • Conservative management & supportive care
  • Biomarkers for early CKD detection

Digestive & Liver Diseases

  • Non-alcoholic fatty liver disease (NAFLD/NASH)
  • Alcoholic liver disease & cirrhosis
  • Viral hepatitis (B, C) & hepatocellular carcinoma
  • Inflammatory bowel disease (Crohn's, ulcerative colitis)
  • Irritable bowel syndrome & functional disorders
  • Chronic pancreatitis & pancreatic insufficiency
  • Celiac disease & food intolerances
  • Liver transplantation & hepatology advances

Musculoskeletal & Autoimmune Disorders

  • Osteoarthritis & rheumatoid arthritis
  • Osteoporosis & fragility fractures
  • Systemic lupus erythematosus & scleroderma
  • Gout & crystal arthropathies
  • Back pain & spinal disorders
  • Biologics & disease-modifying antirheumatic drugs (DMARDs)
  • Physical therapy & rehabilitation strategies
  • Falls prevention in older adults

Epidemiology & Public Health

  • Global & regional NCD burden (mortality, morbidity, DALYs)
  • Risk factors: Tobacco, alcohol, diet, physical inactivity
  • Social determinants of NCDs (poverty, education, urbanization)
  • NCD surveillance systems & health metrics
  • Demographic transition & aging populations
  • Air pollution & environmental NCD risks
  • Health inequalities & vulnerable populations
  • Cost-of-illness & economic burden studies

Prevention & Health Promotion

  • Primary, secondary & tertiary prevention strategies
  • Tobacco control (MPOWER framework, taxation, bans)
  • Healthy diet, salt reduction & sugar-sweetened beverage taxes
  • Physical activity promotion & built environment
  • Alcohol harm reduction policies
  • Workplace wellness & school-based interventions
  • Community-based NCD prevention programs
  • Digital health for prevention (apps, wearables, telehealth)

Health Systems & NCD Management

  • Integrated NCD care models (WHO PEN, HEARTS)
  • Primary health care strengthening for NCDs
  • Universal health coverage (UHC) & NCD financing
  • Task-sharing & community health worker models
  • Essential medicines & technologies for NCDs
  • NCD monitoring & evaluation frameworks
  • Health information systems for NCDs
  • Public-private partnerships in NCD care

Nutrition & Lifestyle Medicine

  • Dietary patterns & NCD risk (Mediterranean, DASH, plant-based)
  • Ultra-processed foods & metabolic health
  • Micronutrient deficiencies & supplementation
  • Intermittent fasting & chrononutrition
  • Behavioral change theories for lifestyle modification
  • Motivational interviewing & counseling techniques
  • Food environments & policy interventions
  • Nutrigenomics & personalized nutrition

Digital Health & Technology in NCDs

  • Telemedicine & remote patient monitoring
  • Mobile health (mHealth) apps for self-management
  • Artificial intelligence for NCD risk prediction
  • Wearable devices (smartwatches, continuous monitors)
  • Electronic health records & NCD registries
  • Clinical decision support systems
  • Virtual rehabilitation & digital therapeutics
  • Data privacy & ethical considerations

Palliative & End-of-Life Care

  • Symptom management (pain, dyspnea, fatigue)
  • Advance care planning & goals of care discussions
  • Hospice care & home-based palliative services
  • Psychosocial & spiritual support for patients & families
  • Caregiver burden & support interventions
  • Pediatric palliative care for NCDs
  • Opioid availability & regulatory barriers
  • Quality of life assessment tools


NCDs in Special Populations

  • Children & adolescents (obesity, type 2 diabetes, hypertension)
  • Women (gestational diabetes, breast/cervical cancer)
  • Older adults (multimorbidity, polypharmacy)
  • Indigenous & tribal populations
  • Refugees & displaced persons
  • Low- & middle-income countries (LMICs)
  • People with disabilities
  • Occupational NCDs & workplace exposures

Emerging & Interdisciplinary Areas

  • Epigenetics & developmental origins of NCDs (DOHaD)
  • Gut microbiome & chronic disease
  • Climate change & NCDs (heat stress, air pollution, food security)
  • One Health approach to NCDs (environmental & animal links)
  • NCDs & infectious disease interactions (HIV, TB, COVID-19)
  • Precision medicine & pharmacogenomics
  • NCD research methodologies & implementation science
  • Patient advocacy & community engagement

 

Registration Fees
Foreign Amount
Delegate Presenter / Author (Oral) 290 USD
Delegate Student Presenter / Author (Oral) 260 USD
Virtual Delegate 230 USD
Accompanying Person / Delegate Listener 260 USD
E-Poster Presentation (Remote Delegate) 175 USD
Important Dates
  • Paper/Abstract submission deadline
    29th December 2026
  • Notification of acceptance
    Within 21 Days (+/-3)
  • Full paper submission deadline
    28th February 2027
  • Registration Deadline
    5th February 2027
  • Conference Date
Note

Early Notification of Acceptance for Abstract/Papers submitted before the deadline will be provided on a rolling basis (within 21 days on a FIFO basis)